MJardin, which trades on the Canadian Securities Exchange as MJAR, announced Tuesday it closed and transferred the license of Las Vegas-based GreenMart of Nevada.
More on MJardin’s move can be found in the company’s news release.
Event News
Reasons not to miss MJBizCon:
News Briefs
-
Bloom Farms, Cura Partners settle marijuana lawsuit
October 11, 2019Cannabis company Hexo’s stock craters on bad news
October 11, 2019Nevada governor forms marijuana task force to attack corruption
October 11, 2019Cannabis companies scale back plans as access to capital tightens
October 10, 2019 -
Los Angeles attorneys group creates cannabis law practice area
October 10, 2019New Frontier Data paying $10 million for cannabis research firm
October 9, 2019 -
Criminal charges dropped against Massachusetts marijuana grower
October 7, 2019FDA warns against vaping cannabis products containing THC
October 4, 2019
News Briefs
-
Cannabis company Hexo’s stock craters on bad news
October 11, 2019Cannabis companies scale back plans as access to capital tightens
October 10, 2019Price gap grows in Canada between legal, illicit cannabis
October 9, 2019 -
Canadian cannabis firms burn through cash amid ‘unmitigated retail disaster’
September 27, 2019Auxly Cannabis closes CA$123 million investment from tobacco giant Imperial Brands
September 26, 2019Canada ‘falling woefully short’ of displacing illicit cannabis market, researcher says
September 25, 2019Why earnouts matter in cannabis M&A
September 25, 2019Australian capital legalizes recreational marijuana
September 25, 2019 -
Auxly Cannabis Group partner Sunens closes CA$84M credit facilities with Bank of Montreal
September 25, 2019European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says
September 23, 2019Cresco Labs, Origin House near closing cannabis deal
September 17, 2019Reports: Former cannabis heavyweight Tikun Olam to sell Israeli assets for $42 million
September 17, 2019Teva Israeli subsidiary signs cannabis distribution deal
September 13, 2019
Follow Us
October Issue
With the rise of adult use cannabis, experts see medical marijuana dominated by two distinct markets.Read the Issue
Get Our Daily Email
Get our daily email
We value your Privacy.